the SPD company Dr Clive Simon, Principal, The SPD Company.

Size: px
Start display at page:

Download "the SPD company Dr Clive Simon, Principal, The SPD Company."

Transcription

1 the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated pharmaceuticals, medical devices, biotechnology, OTC, complementary medicines and animal health industries. SPD concentrates on Regulatory Affairs, Quality, New Product Development, Supply Chain Logistics & Manufacturing Operations, Due Diligence and Litigation support. SPD s core and contract personnel are highly skilled in the technical and managerial arenas, with many years extensive industry experience. Every project is either personally undertaken, or carefully monitored, by SPD s Principal, Dr Clive Simon. Founded in 2004, our boutique consulting company puts people, systems and skills in place until the need for our services becomes redundant. Dr Clive Simon, Principal, The SPD Company. The SPD Company thrives on tough consulting projects. We bring a unique formula of capabilities and speak with authority on the scientific and regulatory aspects of life sciences product challenges. At the same time, SPD fully understands the business of profitability and commercialisation.

2 Regulatory Affairs SPD specialises in the area of Regulatory Affairs, guiding you through the minefield of regulations and rules within TGA, Medsafe, FDA, EU and Asian regulatory bodies. Advising on regulatory strategy & costing Conducting gap analyses of submission dossiers Generating required documentation Collating submission dossiers and applying for product registration for submission to TGA, FDA and other bodies Streamlining regulatory processes and procedures Evaluating staff skills gaps and mentoring employees where needed Project management As an extension of our GMP and regulatory function, Clive (SPD) is a great sounding board when facing challenging opportunities Technical Manager, Australian home-grown OTC company Specific examples: Prescription Medicines NCE and Generics Cat1 applications, Literature-based Submissions, Cat 3, SAR and SRR variations, All aspects of creating Modules 1, 2 and 3, Regulatory strategy for clinical trials. OTCs New product and variation submissions, Dossier documents creation (CMC and clinical). Complementary Medicines New product submissions, Dossiers created: Labels, Specifications, Table of Clinical Evidence. Medical Devices - Numerous class I, II and III applications, Conformity assessment technical files, reports: Clinical Evaluation, Risk Assessment, Essential Principles Requirements, QMS development: ISO 9001, Biologicals Technical file for haemopoietic progenitor cells, TGO 75 procedures and systems, blood and tissues QMS for GMP audits, biosimilar applications. and general projects undertaken In the Medicines & Devices space: Most therapeutic areas covered, e.g. cardiovascular, anti-depressants, oncology, dialysis. Applications submitted in NeeS, CTD and ectd format. Special Access Scheme applications. PQRs creation. the Clinical Evaluation Labels and advertising/promotional materials. reports that (SPD) generated GMP clearance applications and maintenance. for us were of high quality PBS listing - minor submissions and secretariat QREM Manager, Global pharmaceutical company listings, access to experts for more complex applications.

3 Quality Assurance & Compliance SPD works closely with you and your suppliers in preparing for internal and external audits such as: TGA, GMP, APVMA, EU, FDA, Medsafe, ISO 9001 and ISO Reviewing documentation and processes and moulding these into compliance Developing sustainable QA systems Auditing facilities and Quality Management Systems for compliance Project management On-the-job mentoring where required Specific examples: Systems development of product launch processes and computerised systems validation. Development of post-marketing systems - change control, recalls, pharmacovigilance, sponsor requirements. New Product Development From great ideas to the retail pharmacy s shelf... SPD assists you in every aspect of concept development, IP assessment, design, development and manufacturing processes. Facilitating brainstorm sessions for concept development Assessing intellectual property, access to IP experts Designing and developing products and their control tests Developing manufacturing processes Supporting manufacturing site design and construction Validating processes and facilities Project managing and implementing optimal new product launch processes, eg. product portfolio analysis and selection systems development Supply Chain & Manufacturing Operations SPD provides solutions to help optimise your supply chain processes. Undertaking detailed gap analyses Addressing inefficiencies in supply chain, optimising processes Setting up and maintaining supply chain processes Due Diligence & Technical Feasibility SPD provides technical guidance for potential acquisitions of products, manufacturing sites and/or enterprises, both in Australia and overseas. Investigating the robustness of product technology Evaluating product integrity and potential as a commercially-viable option Assessing the technical and financial viability of the product manufacturing capability Technical feasibility and due diligence audits on factories, businesses and products with the aim of clients acquiring or in-licensing them

4 Litigation SPD empowers your legal teams with specialist knowledge and understanding during litigation proceedings. Providing impartial advice in litigation matters Clarifying technical aspects Offering expert witness services for court cases SPD's Dr Clive Simon is a pleasure to work with, and his reports are comprehensive and persuasive. SPD has been a terrific asset in our long-running litigation. Lawyer, Sydney legal firm dealing in pharmaceutical litigation A Network of Specialists In addition to its own personnel, SPD has access to a network of specialist technical service providers in areas such as: Laboratory and bench tests chemistry and microbiology Pre-clinical and clinical trials Reimbursement Literature searches Statistical analysis Advertising material development and assessment Manufacturing and repackaging Post-marketing monitoring and pharmacovigilance I am personally pleased to have SPD on our team & give SPD our highest recommendation! MD, Sydney-based pharmaceutical company SPD provides a number of relevant forums for skills development, primarily through its mentoring programme and its Techgistics series of workshops in the pharmaceuticals and medical devices space. Mentoring Locating talented staff with the right skills set is becoming increasingly difficult in the competitive market for high performers. One strategy to overcome this is to hire people with great potential, but who may be deficient in some or all of the required skills. The mentoring offered by SPD allows these people to be trained as they grow into their roles. SPD offers flexible support whether it be on-site, on-the-job hand-holding to periodic feedback and sounding board sessions either face-to-face or telephonically.

5 Techgistics Workshops The Techgistics Workshop Series was developed specifically to address critical knowledge gaps within these highly technical specialist industries. Our approach is to simulate real-life situations as closely as possible. Your company can experience these workshops in different ways: Open forums which allow sharing of ideas with industry peers, or a closed, company-only forum, either on-site or at an external venue. Techgistics Workshops are available in a number of platforms, namely: Off-the-shelf (ready-to-go) workshops. Partially-customised workshops which are based on an existing topic, with Case Studies relevant to your company situations. Fully-customised workshops typically constructed on a problem area or situation currently experienced by your company. NOTE: SPD has worked internally with local, North American and European clients, as well as with educational institutions such as Box Hill TAFE, UTS and other industry associations to develop workshops that are much-needed within our industry. As a result, SPD is able to offer a wide repertoire of learning themes in the Techgistics Workshop Series, such as: Medical Devices Unplugged - helping minimise the chances of TGA rejection. Dossier Gap Analysis - will your dossier make the cut? Product Development & Launch Processes in a highly-regulated industry. An Intro into Regulatory Affairs, covering prescriptions, OTCs and Medical Devices. Regulatory Affairs for non-regulatory people. How to Create and Review Dossiers to Register Sterile Products. Conformity Assessment Procedures for Medical Devices. Project Management in a technical and highly regulated industry. Planning for Commercialisation. Conducting Due Diligence. Marketing in a highly regulated environment. Supply Chain. QbD. Quality. Drug Discovery - where it all begins. Risk Assessment - a practical how-to guide. (there was) practical information to use and (take) back to the workplace Senior Regulatory Affairs Associate, Medical Device company (the workshop helped) to identify communication gaps between marketing and Reg Affairs Marketing Manager, Sydney-based medical device company

Healthcare and Life Sciences

Healthcare and Life Sciences Healthcare and Life Sciences Introduction Uría Menéndez is an independent law firm that was founded in Madrid in 1946 by Professor Rodrigo Uría González. We currently have seventeen offices in Spain, Portugal,

More information

peace of mind For from development to commercial supply

peace of mind For from development to commercial supply For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number

More information

Value Paper. Are you PAT and QbD Ready? Get up to speed

Value Paper. Are you PAT and QbD Ready? Get up to speed Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more

More information

PATENT ATTORNEYS TRADE MARK ATTORNEYS

PATENT ATTORNEYS TRADE MARK ATTORNEYS PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need

More information

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical

More information

2008 Course Programs Schedule

2008 Course Programs Schedule 2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)

More information

Does your company know about IP rights and use them effectively to achieve business growth and protection?

Does your company know about IP rights and use them effectively to achieve business growth and protection? IP CONSULT SERIES: REALISING THE POTENTIAL OF YOUR INTELLECTUAL PROPERTY SYNOPSIS Does your company know about IP rights and use them effectively to achieve business growth and protection? This seminar

More information

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total SCIENCE + BEAUTY Technical Expertise for the Beauty Industry 6 pages total We can help you with a single scientific requirement Or take a full 360 o approach An Experienced Partner Schoon Scientific is

More information

Intellectual Property, Vaccine Production and Technology Transfer

Intellectual Property, Vaccine Production and Technology Transfer Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations

More information

Swissmedic, Swiss Agency for Therapeutic Products

Swissmedic, Swiss Agency for Therapeutic Products PMDA International Forum, 8 February 2014 Swissmedic, Swiss Agency for Therapeutic Products Jürg H. Schnetzer, Executive Director Grüezi. Bonjour. Buongiorno. Allegra. 2 Overview Swissmedic Introduction

More information

PATENT ATTORNEYS TRADE MARK ATTORNEYS

PATENT ATTORNEYS TRADE MARK ATTORNEYS PATENT ATTORNEYS TRADE MARK ATTORNEYS 02 INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need

More information

Jean W. Frydman Partner

Jean W. Frydman Partner Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary

More information

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com

More information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,

More information

PDA 71 Years of Connecting People, Science and Regulation

PDA 71 Years of Connecting People, Science and Regulation PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International

More information

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective 14 th DIA Japan Annual Meeting 2017 November 12-14, 2017 Tokyo Big Sight Ariake ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective Yasuhiro Kishioka, Ph.D. Principal Reviewer Office

More information

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant

More information

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC

More information

Technology Leadership Course Descriptions

Technology Leadership Course Descriptions ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills

More information

Integrated Scientific Advice Workshop: ISPOR Glasgow

Integrated Scientific Advice Workshop: ISPOR Glasgow Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered

More information

Life Sciences IP Report

Life Sciences IP Report Life Sciences IP Report Facts & Analysis In Partnership With 2017 Consero Group. Reproduction Prohibited. January 2017 Introduction Life Sciences IP Report The competitive advantage for businesses in the

More information

The Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation

The Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation The Product Journey An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation This one day conference will be held on 16th September The conference day will include speakers from

More information

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution

More information

1. Protecting the work and expressing the potential of our clients' companies

1. Protecting the work and expressing the potential of our clients' companies Turin, December, 2012 PRESS FOLDER 1. Protecting the work and expressing the potential of our clients' companies 2. Over a century of solid experience and steady growth 3. A network of excellence 4. Leadership

More information

Submission to the Productivity Commission inquiry into Intellectual Property Arrangements

Submission to the Productivity Commission inquiry into Intellectual Property Arrangements Submission to the Productivity Commission inquiry into Intellectual Property Arrangements DECEMBER 2015 Business Council of Australia December 2015 1 Contents About this submission 2 Key recommendations

More information

Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs

Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs Antitrust 1. Anti-Counterfeiting for Licensed Products: What You Don't Know Can Hurt Your Business 2. Antitrust Investigations:

More information

Firm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees.

Firm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees. Firm Overview At Lahive, our thinking expands yours. Our lawyers and technical specialists practice at the cutting edge of intellectual property, with special expertise in biotechnology, chemistry, high

More information

Manmin. IP & LAW Firm

Manmin. IP & LAW Firm Manmin IP & LAW Firm Who are you thinking of putting on your valuable IP rights? Reliable service in Intellectual Property To success in the global market, it is necessary to value your IP rights correctly

More information

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A

More information

CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS

CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect

More information

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of

More information

Your Content Your Way

Your Content Your Way MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own

More information

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure HOTELS, TOURISM & LEISURE nem is one of Australasia s largest boutique business consultancy firms, which is able to draw on the significant skills and experience of over 50 partners across Australia and

More information

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA WORLD COMPLIANCE SEMINARS SPEAKER:- BRIAN G. NADEL President of Brian G. Nadel, GMP Consulting, LLC. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017

More information

JUST SCRATCHING THE SERVICE

JUST SCRATCHING THE SERVICE CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5

More information

Implementing Quality Systems

Implementing Quality Systems Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving

More information

Connecting People, Science and Regulation

Connecting People, Science and Regulation Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway Suite 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm

More information

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association

More information

Clinical Forum Attendee Sample Job Titles

Clinical Forum Attendee Sample Job Titles Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.

More information

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) MFDS Nov 11, 2016 1 Agenda Introduction of PMDA ICH Q12 QbD assessment

More information

Environmental Protection Agency

Environmental Protection Agency Good Laboratory Management: Means compliance with the correct regulations for each individual study.. Environmental Protection Agency Established 1970 To enforce environmental protection standards Clean

More information

Leader in Pharmaceutical Films

Leader in Pharmaceutical Films TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation

More information

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective 1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation

More information

Quality and GLP for Histology and Pathology of Drug Safety Studies

Quality and GLP for Histology and Pathology of Drug Safety Studies Quality and GLP for Histology and Pathology of Drug Safety Studies Roger Alison BVSc MRCVS DiplECVP Consultant Toxicological Pathologist What is Quality Histology? It depends upon the purpose - Answer

More information

Standards in. International Trade & Nuclear Safety. The Role of IAEA

Standards in. International Trade & Nuclear Safety. The Role of IAEA The Role of Standards in International Trade & Nuclear Safety IAEA International Atomic Energy Agency International Atomic Energy Agency Technical Meeting on Shared Experiences and Lessons Learned from

More information

QANTM Intellectual Property Limited (ASX: QIP)

QANTM Intellectual Property Limited (ASX: QIP) QANTM Intellectual Property Limited (ASX: QIP) INFORMATION FOR POTENTIAL INVESTORS KEY INFORMATION Listed: 31 August 2016 Sector: Industrials ASX 200 Weighting: 0% Share Price Range: August 2016 October

More information

Training Prospectus Public Course Dates

Training Prospectus Public Course Dates Training Prospectus 2018 Public Course Dates Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries, the Honeyman

More information

Samil Forensic Services

Samil Forensic Services www.samil.com Samil Forensic Services Investigation Dispute Support Forensic Tech Fraud. Corruption. Cybercrime. Regulatory investigations. Financial misrepresentation. Intellectual property disputes.

More information

Training Overview. Europe 2015

Training Overview. Europe 2015 Training Overview Europe 2015 Welcome to the Synergy Health Applied Sterilisation Technologies (AST) Training Brochure The AST training programme offers a variety of opportunities to organisations wishing

More information

Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE

Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE Medical Device Expert (21 years with FDA, 18 years in the device industry) Planning, implementing, and managing

More information

Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences

Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching

More information

YOU CREATE. YOU INNOVATE. WE PROTECT.

YOU CREATE. YOU INNOVATE. WE PROTECT. Patent Brochure YOU CREATE. YOU INNOVATE. WE PROTECT. Unique. Just like your ideas. Whether you are managing a large, multi-national patent portfolio or pursuing funding to jump-start your portfolio, Brooks

More information

TRIPS and Access to Medicines. WR Briefing

TRIPS and Access to Medicines. WR Briefing TRIPS and Access to Medicines WR Briefing Outline What is TRIPS How does it affect access to medicines What are the TRIPS flexibilities? What are extra-trips provisions? How do the extra-trips provisions

More information

Antitrust & Competition

Antitrust & Competition Antitrust & Competition Mayer Brown s multi-disciplinary Antitrust & Competition team offers a seamless, coordinated service throughout the Asia Pacific region, and has the benefit of extensive regional

More information

TERMS OF REFERENCE FOR CONSULTANTS

TERMS OF REFERENCE FOR CONSULTANTS Strengthening Systems for Promoting Science, Technology, and Innovation (KSTA MON 51123) TERMS OF REFERENCE FOR CONSULTANTS 1. The Asian Development Bank (ADB) will engage 77 person-months of consulting

More information

innovation for discovery Campwood Road, Rotherwas Industrial Estate, Hereford, HR2 6JD T: +44 (0) F: +44 (0)

innovation for discovery Campwood Road, Rotherwas Industrial Estate, Hereford, HR2 6JD T: +44 (0) F: +44 (0) Campwood Road, Rotherwas Industrial Estate, Hereford, HR2 6JD T: +44 (0)1432 379111 F: +44 (0)1432 344960 www.arrowmight.com innovation for discovery innovation for discovery Critical environments are

More information

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded

More information

Science and mathematics

Science and mathematics Accreditation of HE Programmes (AHEP): Collated learning outcomes for six areas of learning Programmes accredited for IEng Engineering is underpinned by science and mathematics, and other associated disciplines,

More information

Emerged! Professional Intermediate Study Coordinator Training Workshop

Emerged! Professional Intermediate Study Coordinator Training Workshop Emerged! Professional Intermediate Study Coordinator Training Workshop Speaker Profile Topic in Emerged! workshop Dr Cheong Yuet Meng President, Society of Clinical Research Professionals Malaysia (SCRPM)

More information

University joins Industry: IP Department. Georgina Marjanet Ferrer International, SA

University joins Industry: IP Department. Georgina Marjanet Ferrer International, SA University joins Industry: IP Department Georgina Marjanet Ferrer International, SA Topics Ø What is IP? Ø Importance of IP in the pharmaceutical industry Ø IP Department: tasks and responsibilities Ø

More information

WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010

WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 Prepared & Presented by: Gwen Connon, Contract Specialist, WRHA Contracting Services Sarah Kelso, Manager, Clinical Engineering,

More information

China: Managing the IP Lifecycle 2018/2019

China: Managing the IP Lifecycle 2018/2019 China: Managing the IP Lifecycle 2018/2019 Patenting strategies for R&D companies Vivien Chan & Co Anna Mae Koo and Flora Ho Patenting strategies for R&D companies By Anna Mae Koo and Flora Ho, Vivien

More information

IMPROVING PATIENTS SELF-INJECTION EXPERIENCE

IMPROVING PATIENTS SELF-INJECTION EXPERIENCE IMPROVING PATIENTS SELF-INJECTION EXPERIENCE Jeff Lettman, Senior Research & Design Engineer, and Josh Hopkins, Engineering Manager,, explain how they worked with a client to develop a product that would

More information

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036 2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop

More information

Draft Plan of Action Chair's Text Status 3 May 2008

Draft Plan of Action Chair's Text Status 3 May 2008 Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background

More information

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008 PROGRAM ANNOUNCEMENT November 2007 Institution: New Program Title: Degree Designation: Degree Abbreviation: CIP Code and Nomenclature (if possible): Campus(es) where the program will be offered: Date when

More information

Monitoring R&D resource flows: Global resources and challenges

Monitoring R&D resource flows: Global resources and challenges WHO informal workshop: Wellcome Trust, London 14 February 2013 Monitoring R&D resource flows: Global resources and challenges Stephen Matlin Institute of Global Health Innovation Imperial College, London

More information

Turnkey Cleanroom Solutions.

Turnkey Cleanroom Solutions. Turnkey Cleanroom Solutions www.weiss-technik.com Ultraclean /Ultraconstant Turnkey Clean Room Solutions Weiss Klimatechnik provides you with system solutions and components for all clean room applications.

More information

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market 2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region Intellectual Property Protecting Your Assets in a Volatile Market Thursday, October 1, 2015 (2:45 p.m. 3:15 p.m.) Presented

More information

World Class Intellectual Property Services

World Class Intellectual Property Services World Class Intellectual Property Services Contents Exceptional service in Intellectual Property 1 A world class service 2 Patents 4 Trademarks 8 Designs 10 Our attorneys 12 International networks and

More information

Turning the wheels of your success

Turning the wheels of your success INDUSTRIAL SERVICES Turning the wheels of your success A comprehensive package of integrated services combining traditional certification and inspection with innovative business solutions based on the

More information

Future of Pharmaceutical Quality and the Path to Get There

Future of Pharmaceutical Quality and the Path to Get There Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,

More information

UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS

UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure,

More information

Overview and Version 3.1.0

Overview and Version 3.1.0 Overview and Version 3.1.0 The sponsor and the investigator shall keep a clinical trial master file. The clinical trial master file shall at all times contain the essential documents relating to that clinical

More information

9 Vaccine SMEs' Needs

9 Vaccine SMEs' Needs 9 Vaccine SMEs' Needs As in most innovative sectors, SMEs play a critical role in bridging basic discoveries from academic research to clinical development 36. This could be seen over the last decade with

More information

J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL (office) (mobile)

J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL (office) (mobile) J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL 62024 314-499-5148 (office) 714-473-0863 (mobile) Larry@fdadeviceexpert.com INTRODUCTION: Over 20 years of FDA experience encompassing virtually

More information

TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations

TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations MTAA Response - October 2017 October 2017 Australian Regulatory Considerations Page 1 of 7 Level

More information

Section heading. Strapline sub-heading

Section heading. Strapline sub-heading Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide

More information

Inter-Association Task Force

Inter-Association Task Force Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force

More information

OECD-INADEM Workshop on

OECD-INADEM Workshop on OECD-INADEM Workshop on BUILDING BUSINESS LINKAGES THAT BOOST SME PRODUCTIVITY OUTLINE AGENDA 20-21 February 2018 Mexico City 2 About the OECD The Organisation for Economic Co-operation and Development

More information

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS Nataliia Revutska, Assistant Prof. Taras Shevchenko National University of Kyiv, Ukraine Abstract The paper considers the characteristics of two

More information

CEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC

CEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: July 10, 2017 Human Factors Firm helping Medical Device and Pharmaceutical Companies Ensure Usability, Safety, Instructions and Training

More information

Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use

Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Document issued on: November 30, 2004 The draft of this document

More information

Office of Pharmaceutical Quality: Why, What, and How?

Office of Pharmaceutical Quality: Why, What, and How? Office of Pharmaceutical Quality: Why, What, and How? Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research NIPTE Annual Scientific Conference

More information

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy. API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our

More information

Instrumentation and Control

Instrumentation and Control Program Description Instrumentation and Control Program Overview Instrumentation and control (I&C) and information systems impact nuclear power plant reliability, efficiency, and operations and maintenance

More information

NCRIS Capability 5.7: Population Health and Clinical Data Linkage

NCRIS Capability 5.7: Population Health and Clinical Data Linkage NCRIS Capability 5.7: Population Health and Clinical Data Linkage National Collaborative Research Infrastructure Strategy Issues Paper July 2007 Issues Paper Version 1: Population Health and Clinical Data

More information

Annual Benefit-Risk Workshop

Annual Benefit-Risk Workshop Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The

More information

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC Curriculum Vitae Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC cnelson@infact-experts.com Salt Lake City Office 175 South Main Street, Suite 630 Salt

More information

Managing IP Assets Throughout the. Patent Lifecycle

Managing IP Assets Throughout the. Patent Lifecycle Managing IP Assets Throughout the Patent Lifecycle You or your clients have invested heavily in developing and acquiring intellectual property. In some cases you may have been threatened by others with

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

Intellectual Property

Intellectual Property Intellectual Property 1 Overview In a progressively uncertain economy, counterfeit products are becoming more prevalent particularly in Vietnam. Therefore, companies should be increasingly vigilant in

More information

Office of Pharmaceutical Quality Key Quality Initiatives

Office of Pharmaceutical Quality Key Quality Initiatives Office of Pharmaceutical Quality Key Quality Initiatives Ashley B. Boam, MSBE Director Office of Policy for Pharmaceutical Quality Office of Pharmaceutical Quality Center for Drug Evaluation and Research

More information

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team

More information

February 5, 2010 VIA ELECTRONIC SUBMISSION

February 5, 2010 VIA ELECTRONIC SUBMISSION February 5, 2010 VIA ELECTRONIC SUBMISSION Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Current Good Manufacturing Practice

More information

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 www.euipo.europa.eu INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 Executive Summary JUNE 2016 www.euipo.europa.eu INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 Commissioned to GfK Belgium by the European

More information

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 www.euipo.europa.eu INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 Executive Summary JUNE 2016 www.euipo.europa.eu INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016 Commissioned to GfK Belgium by the European

More information

Intellectual Property

Intellectual Property Intellectual Property Clients from many industries entrust their intellectual property ( IP ) matters to the highly qualified lawyers at Goulston & Storrs. Our clients want smart and savvy counsel that

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

ONR Strategy 2015 to 2020

ONR Strategy 2015 to 2020 Title of publication ONR Strategy 2015 to 2020 Office for Nuclear Regulation Page 1 of 5 Introduction Nick Baldwin, Chair The Energy Act 2013 provided for the creation of ONR as an independent, statutory

More information